Segui
Julie Voss
Julie Voss
Email verificata su uth.tmc.edu
Titolo
Citata da
Citata da
Anno
Protease-activatable adeno-associated virus vector for gene delivery to damaged heart tissue
CM Guenther, MJ Brun, AD Bennett, ML Ho, W Chen, B Zhu, M Lam, ...
Molecular Therapy 27 (3), 611-622, 2019
432019
Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting
SC Ghosh, S Hernandez Vargas, M Rodriguez, S Kossatz, J Voss, ...
ACS medicinal chemistry letters 8 (7), 720-725, 2017
282017
Specific targeting of somatostatin receptor subtype-2 for fluorescence-guided surgery
S Hernandez Vargas, S Kossatz, J Voss, SC Ghosh, HS Tran Cao, ...
Clinical Cancer Research 25 (14), 4332-4342, 2019
252019
Evaluation of anti-LGR5 antibodies by immunoPET for imaging colorectal tumors and development of antibody–drug conjugates
A Azhdarinia, J Voss, SC Ghosh, JA Simien, S Hernandez Vargas, J Cui, ...
Molecular Pharmaceutics 15 (6), 2448-2454, 2018
182018
A modular dual-labeling scaffold that retains agonistic properties for somatostatin receptor targeting
SC Ghosh, M Rodriguez, KS Carmon, J Voss, NL Wilganowski, ...
Journal of Nuclear Medicine 58 (11), 1858-1864, 2017
102017
Development of a drug–device combination for fluorescence-guided surgery in neuroendocrine tumors
S Hernandez Vargas, C Lin, J Voss, SC Ghosh, DM Halperin, ...
Journal of biomedical optics 25 (12), 126002-126002, 2020
82020
A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery
SH Vargas, C Lin, S AghaAmiri, J Voss, N Ikoma, HST Cao, SC Ghosh, ...
Molecular-Guided Surgery: Molecules, Devices, and Applications VI 11222, 61-72, 2020
42020
Comparison of HER2-targeted antibodies for fluorescence-guided surgery in breast cancer
S AghaAmiri, J Simien, AM Thompson, J Voss, SC Ghosh, ...
Molecular imaging 2021, 1-12, 2021
22021
Abstract P1-02-01: HER2/neu antibody-fluorophore conjugate for intraoperative detection of HER2-positive breast cancer
J Simien, J Voss, AM Thompson, SC Ghosh, S AghaAmiri, A Azhdarinia, ...
Cancer Research 80 (4_Supplement), P1-02-01-P1-02-01, 2020
2020
A highly specific somatostatin analog for fluorescence-guided surgery
SH Vargas, S Ghosh, J Voss, J Simien, S Kossatz, T Reiner, A Azhdarinia
Journal of Nuclear Medicine 60 (supplement 1), 1022-1022, 2019
2019
Dual Labeling as a Tool for Cross-Validating the Imaging Properties of a Hybrid Somatostatin Analog
SH Vargas, SC Ghosh, J Voss, J Simien, A Azhdarinia
PANCREAS 48 (3), 438-438, 2019
2019
Quantitative assessment of fluorescence uptake by dual labeling
A Azhdariniaa, SH Vargasa, J Vossa, S Ghosha
Abstracts/Nuclear Medicine and Biology 72 (73/S1), S1-S67, 2019
2019
Synthesis and in vivo characterization of a 68Ga/NIR labeled peptide for somatostatin receptor targeting
S Ghosh, SH Vargas, J Voss, K Carmon, A Azhdarinia
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Synthesis and Characterization of a 68Ga/NIR Labeled Peptide for Somatostatin Receptor Targeting
S Hernandez-Vargas, S Ghosh, J Voss, D Lee, M Schultz, A Azhdarinia
Synthesis 100, 27, 2018
2018
Synthesis and characterization of a 68Ga/NIR labeled peptide for somatostatin receptor targeting
SH Vargas, S Ghosh, J Voss, D Lee, M Schultz, A Azhdarinia
Journal of Nuclear Medicine 58 (supplement 1), 269-269, 2017
2017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–15